Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 1/2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1

Interventions

pembrolizumab 259Cyclophosphamide 242Specimen Handling 199fludarabine 174Magnetic Resonance Spectroscopy 174Biopsy 148Nivolumab 119Carboplatin 98Radiotherapy 92Paclitaxel 84venetoclax 82Cisplatin 81fludarabine phosphate 79Gemcitabine 79Injections 69Ipilimumab 63Dexamethasone 61atezolizumab 59Bevacizumab 59Cetuximab 57Azacitidine 56Radiation 55Fluorouracil 55durvalumab 54Radiosurgery 52Temozolomide 47Rituximab 44Oxaliplatin 44Irinotecan 43Docetaxel 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Biopsy, Large-Core Needle × 1 year × Clear all
NCT04024878 2025-06-18

NeoVax With Nivolumab in Patients With Ovarian Cancer

Dana-Farber Cancer Institute

Phase 1 Active not recruiting
22 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡